Phase 1 evaluation of ASP3082 in KRAS G12D-mutant pancreatic ductal adenocarcinoma: Pharmacokinetic and biomarker insights 

Wungki Park et al.

Avacincaptad pegol for GA: 3-year results from the GATHER2 open-label extension trial
zolbemicrosite-unbranded-north-america-global-en-banner-mobile.png

Supplementary data

Presentation content summarized in plain language